Obinutuzumab
GZL
Unknown small_molecule active
Quick answer
Obinutuzumab for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active